Azvudine
- Generic Name
- Azvudine
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11FN6O4
- CAS Number
- 1011529-10-4
- Unique Ingredient Identifier
- IJ2XP0ID0K
Overview
Azvudine is under investigation in clinical trial NCT04668235 (Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (Sars-cov-2 Infected)).
Background
Azvudine is under investigation in clinical trial NCT04668235 (Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (Sars-cov-2 Infected)).
Indication
⑴用于与核苷逆转录酶抑制剂及非核苷逆转录酶抑制剂联用，治疗高病毒载量的成年HIV-1感染患者。 ⑵用于治疗普通型新型冠状病毒肺炎（COVID-19）成年患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath